 Parenteral ofloxacin treatment pyelonephritis interim findings studies intravenous ofloxacin treatment pyelonephritis findings center multicenter trial first study intravenous IV ofloxacin patients urine-culture-positive pyelonephritis days intravenous therapy patients oral ofloxacin Microbiologic eradication percent clinical cures percent patients ofloxacin probable drug-related adverse events second comparative study patients pyelonephritis IV ofloxacin option oral ofloxacin days IV ceftazidime patients pyelonephritis option TMP/SMX days Microbiologic cures percent ofloxacin patients percent ceftazidime patients Probable drug-related adverse reactions ofloxacin patients none ceftazidime patients interim study findings intravenous preparation ofloxacin efficacious treatment pyelonephritis safe addition IV ofloxacin efficacious IV ceftazidime treatment pyelonephritis